You are here

  • David J. Sugarbaker, MD

    Baylor College of Medicine, Lung Institute, and Division of Thoracic Surgery , Baylor St. Luke’s Medical Center, Houston, TX, USA

    David Sugarbaker is a nationally and internationally recognized surgeon specializing in the treatment of mesothelioma. He is currently the Olga Keith Weiss Chair of Surgery at Baylor College of Medicine, Director of the newly formed Lung Institute, and Chief of the new Division of Thoracic Surgery at Baylor College of Medicine and Baylor St. Luke’s Medical Center in Houston, TX, USA.

    Dr Sugarbaker attended Wheaton College in Wheaton, IL, USA, and then attended Cornell University Medical College in New York, NY, USA. He completed a residency at the Brigham and Women’s Hospital in Boston, MA, USA, and cardiothoracic training at the Toronto General Hospital and Mount Sinai Hospital in Toronto, Canada. In 1998, Dr Sugarbaker was appointed Chief of the newly formed Division of Thoracic Surgery at Brigham and Women's Hospital. Under his 25-year direction, the Division of Thoracic Surgery grew to become one of the largest in the nation

    Dr Sugarbaker is known as a pioneer in the field of mesothelioma, having developed innovative multimodality therapies and directed translation research programs acclaimed worldwide. He has also developed new approaches to the treatment of cancer, and his technique of esophageal removal has been very widely adopted. He founded and directed the International Mesothelioma Program (IMP), which has become one of the largest mesothelioma programs in the world.

    Dr Sugarbaker has published extensively, with more than 200 original papers and over 70 textbook chapters. His textbook on thoracic surgery entitled “Adult Chest Surgery” claimed several awards. Dr Sugarbaker has served as President of the prestigious American Association for Thoracic Surgery (AATS) and is currently the President of the AATS Graham Foundation for a second term.

    Category:
  • Anne Tsao, MD

    University of Texas MD Anderson Cancer Center, Houston, TX, USA

    Dr Anne Tsao is Professor of Medical Oncology at the University of Texas MD Anderson Cancer Center (MDACC), Houston, TX, USA. She specializes in thoracic medical oncology and is a leader in her field for the study of malignant mesothelioma and thoracic oncology. Dr Tsao earned her medical degree from the University of Chicago Pritzker School of Medicine, Chicago, IL, USA, and completed an internship and a residency at Indiana University in Indianapolis, IN, USA, and a medical oncology fellowship at the MDACC. After completing her training, she joined the faculty at MDACC; being board certified in both internal medicine and medical oncology, Dr Tsao specializes in thoracic medical oncology, and currently serves as both the director of the mesothelioma program and the director of the thoracic chemo-radiation program.

    Dr Tsao’s research focuses on individualizing cancer therapy through understanding the molecular mechanisms of disease; she is the principle investigator of several active clinical trials at MDACC and also serves as Co-Chair of the MDACC Clinical Research Committee.

    Dr Tsao has received many awards, including an American Society of Clinical Oncology (ASCO) Merit Award, the MD Anderson Achievement in Research Award, and the ASCO Young Investigator Award. She has authored or co-authored more than 100 publications in high-impact journals such as Journal of Clinical Oncology, Cancer Epidemiology, Biomarkers & Prevention, Journal of Thoracic Oncology, Cancer, Nature Medicine Clinical Oncology, and Molecular Cancer Therapeutics. She is an active member of many national and international oncology societies, including the International Association for the Study of Lung Cancer (IASLC), and the Mesothelioma Applied Research Foundation (MARF). She was selected to participate in the (ASCO) leadership development program, and assists ASCO and the American Association for Cancer Research (AACR) in lobbying US congressional leaders for improved funding for cancer research.

    Category:
  • Jun Zhang, MD

    Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX, USA

    Jun Zhang is an assistant professor in the section of hematology and oncology at the Dan L. Duncan Comprehensive Cancer Center at Baylor College of Medicine in Houston, TX, USA, where she utilizes the latest laboratory discoveries to provide the most advanced personalized care. Dr Zhang is board certified in medical oncology, hematology, and internal medicine. She earned her medical degree from the Hunan Medical University in Changsa, China, and completed an internship and residency at the Brookdale University Hospital in New York, NY, USA, and the New Hanover Regional Medical Center in Wilmington, NC, USA. She then completed fellowship training in hematology and oncology at East Carolina University in Greenville, NC.

    Dr Zhang’s research interests focus on development of novel therapies in thoracic, and head and neck malignancies. She has expertise in treatment of pleural mesothelioma, lung cancer, and head and neck cancer. She is particularly interested in tumor biology and genomic studies, and in diagnosing cancer at a molecular level. She has authored or co-authored articles in peer-reviewed journals, including Journal of Thoracic Oncology, Experimental & Clinical Gastroenterology, and Chinese Journal of Cancer Research.  

    Category:

Video

David J. Sugarbaker, MD
Baylor College of Medicine, Lung Institute, and Division of Thoracic Surgery
Baylor St. Luke's Medical Center
Houston, TX, USA

Share

Infographic

Understanding Malignant Pleural Mesothelioma

Jointly provided by the Elsevier Office of Continuing Medical Education and Excerpta Medica.